Associations Between Statin Treatment and Markers of Inflammation, Vasoconstriction, and Coagulation in Patients With Abdominal Aortic Aneurysm
Gottsater et al.
VASC ENDOVASCULAR SURG 2009;42:567-573.
ABSTRACT
Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community
Melander et al.
JAMA 2009;302:49-57.
ABSTRACT
| FULL TEXT
The Vytorin on Carotid Intima-Media Thickness and Overall Arterial Rigidity (VYCTOR) Study
Meaney et al.
J Clin Pharmacol 2009;49:838-847.
ABSTRACT
| FULL TEXT
Metabolic syndrome: intima-media thickness and beyond.
Golomb
J Am Coll Cardiol 2009;53:2280-2282.
FULL TEXT
Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients: A Randomized Trial
Becker et al.
ANN INTERN MED 2009;150:830-839.
ABSTRACT
| FULL TEXT
Mendelian Randomization: Nature's Randomized Trial in the Post-Genome Era
Thanassoulis and O'Donnell
JAMA 2009;301:2386-2388.
FULL TEXT
Late Clinical Events After Drug-Eluting Stents: The Interplay Between Stent-Related and Natural History-Driven Events
Leon et al.
J Am Coll Cardiol Intv 2009;2:504-512.
ABSTRACT
| FULL TEXT
Effects of Statins on the Pharmacokinetics of Midazolam in Healthy Volunteers
Kokudai et al.
J Clin Pharmacol 2009;49:568-573.
ABSTRACT
| FULL TEXT
Statin Adherence and Risk of Accidents: A Cautionary Tale
Dormuth et al.
Circulation 2009;119:2051-2057.
ABSTRACT
| FULL TEXT
Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease
Karalis
Mayo Clin Proc. 2009;84:345-352.
ABSTRACT
| FULL TEXT
Management of Hyperlipidemia in Older Adults
Alexander et al.
J CARDIOVASC PHARMACOL THER 2009;14:49-58.
ABSTRACT
Carotid Intima-Media Thickness and Coronary Artery Calcium Score as Indications of Subclinical Atherosclerosis
Lester et al.
Mayo Clin Proc. 2009;84:229-233.
ABSTRACT
| FULL TEXT
Pravastatin for Cardiovascular Event Primary Prevention in Patients With Mild-to-Moderate Hypertension in the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study
Kushiro et al.
Hypertension 2009;53:135-141.
ABSTRACT
| FULL TEXT
Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk.
Robinson et al.
J Am Coll Cardiol 2009;53:316-322.
ABSTRACT
| FULL TEXT
Association Between Statin Use and Risk for Keratinocyte Carcinoma in the Veterans Affairs Topical Tretinoin Chemoprevention Trial
Dore et al.
ANN INTERN MED 2009;150:9-18.
ABSTRACT
| FULL TEXT
JUPITER to Earth: A statin helps people with normal LDL-C and high hs-CRP, but what does it mean?
SHISHEHBOR and HAZEN
Cleveland Clinic Journal of Medicine 2009;76:37-44.
ABSTRACT
| FULL TEXT
Statins alter neutrophil migration by modulating cellular Rho activity--a potential mechanism for statins-mediated pleotropic effects?
Maher et al.
J. Leukoc. Biol. 2009;85:186-193.
ABSTRACT
| FULL TEXT
Cholesteryl Ester Transfer Protein Inhibition, High-Density Lipoprotein Raising, and Progression of Coronary Atherosclerosis: Insights From ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation)
Nicholls et al.
Circulation 2008;118:2506-2514.
ABSTRACT
| FULL TEXT
The Metabolic Syndrome
Cornier et al.
Endocr. Rev. 2008;29:777-822.
ABSTRACT
| FULL TEXT
Interaction between statins and clopidogrel: is there anything clinically relevant?
Bhindi et al.
QJM 2008;101:915-925.
ABSTRACT
| FULL TEXT
Primary Prevention and Statins: Is It Just About Going to Class?
Krasuski
Mayo Clin Proc. 2008;83:1313-1315.
FULL TEXT
Comparison of Cardiovascular Event Rates in Patients Without Cardiovascular Disease in Whom Atorvastatin or Simvastatin Was Newly Initiated
Jacobson et al.
Mayo Clin Proc. 2008;83:1316-1325.
ABSTRACT
| FULL TEXT
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments A Network Meta-Analysis Involving More Than 65,000 Patients.
Mills et al.
J Am Coll Cardiol 2008;52:1769-1781.
ABSTRACT
| FULL TEXT
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker et al.
NEJM 2008;359:2195-2207.
ABSTRACT
| FULL TEXT
Statin Use Is Associated with Prolonged Survival of Renal Transplant Recipients
Wiesbauer et al.
J. Am. Soc. Nephrol. 2008;19:2211-2218.
ABSTRACT
| FULL TEXT
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels
Hausenloy and Yellon
Postgrad. Med. J. 2008;84:590-598.
ABSTRACT
| FULL TEXT
Is Red Yeast Rice a Suitable Alternative for Statins?-Reply-I
Becker et al.
Mayo Clin Proc. 2008;83:1294-1296.
FULL TEXT
Lipid-Lowering Therapy is Related to Inflammatory Markers and 3-Year Mortality in Patients With Critical Limb Ischemia
Isma et al.
ANGIOLOGY 2008;59:542-548.
ABSTRACT
Metabolism, Pharmacokinetics, and Excretion of a Cholesteryl Ester Transfer Protein Inhibitor, Torcetrapib, in Rats, Monkeys, and Mice: Characterization of Unusual and Novel Metabolites by High-Resolution Liquid Chromatography-Tandem Mass Spectrometry and 1H Nuclear Magnetic Resonance
Prakash et al.
Drug Metab. Dispos. 2008;36:2064-2079.
ABSTRACT
| FULL TEXT
Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline
Rosenzweig et al.
J. Clin. Endocrinol. Metab. 2008;93:3671-3689.
ABSTRACT
| FULL TEXT
Statins, Low-Density Lipoprotein Cholesterol, and Risk of Cancer
Alsheikh-Ali et al.
J Am Coll Cardiol 2008;52:1141-1147.
ABSTRACT
| FULL TEXT
Targeted versus global approaches to the management of hypercholesterolaemia
Reynolds et al.
The Journal of the Royal Society for the Promotion of Health 2008;128:248-254.
ABSTRACT
Evidence Mandating Earlier and More Aggressive Treatment of Hypercholesterolemia
Steinberg et al.
Circulation 2008;118:672-677.
FULL TEXT
The Role of Statin Drugs in the Management of the Peripheral Vascular Patient
Samson
VASC ENDOVASCULAR SURG 2008;42:352-366.
ABSTRACT
A Practical 'ABCDE' Approach to the Metabolic Syndrome
Blaha et al.
Mayo Clin Proc. 2008;83:932-943.
ABSTRACT
| FULL TEXT
Do People With Diabetes Need Statins?
White
The Diabetes Educator 2008;34:664-673.
ABSTRACT
| FULL TEXT
The Parodox of Glycemic Control and Cardiovascular Complications: Sorting Out the Data
Dokken
Diabetes Spectr. 2008;21:150-152.
FULL TEXT
The Association of Testosterone Levels with Overall Sleep Quality, Sleep Architecture, and Sleep-Disordered Breathing
Barrett-Connor et al.
J. Clin. Endocrinol. Metab. 2008;93:2602-2609.
ABSTRACT
| FULL TEXT
Over-the-Counter Sales of Statins and Other Drugs for Asymptomatic Conditions
Tinetti
NEJM 2008;358:2728-2732.
FULL TEXT
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels
Hausenloy and Yellon
Heart 2008;94:706-714.
ABSTRACT
| FULL TEXT
Almonds Reduce Biomarkers of Lipid Peroxidation in Older Hyperlipidemic Subjects
Jenkins et al.
J. Nutr. 2008;138:908-913.
ABSTRACT
| FULL TEXT
Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes: The SANDS Randomized Trial
Howard et al.
JAMA 2008;299:1678-1689.
ABSTRACT
| FULL TEXT
Primary prevention with pravastatin for 5 years continued to prevent coronary events in the next 10 years
Woodend
Evid. Based Nurs. 2008;11:52-52.
FULL TEXT
Letter Regarding Article by Leeper et al, "Statin Use in Patients With Extremely Low Low-Density Lipoprotein Levels Is Associated With Improved Survival"
Anderson and Salgado
Circulation 2008;117:e174-e174.
FULL TEXT
Applications of statins in cardiothoracic surgery: more than just lipid-lowering
Paraskevas
Eur. J. Cardiothorac. Surg. 2008;33:377-390.
ABSTRACT
| FULL TEXT
HDL-cholesterol modulation and its impact on the management of cardiovascular risk
Ferns and Keti
Ann Clin Biochem 2008;45:122-128.
ABSTRACT
| FULL TEXT
Lifestyle or Life-Saving Medicines? A Primary Healthcare Professional and Consumer Opinion Survey on Over-the-Counter Statins
Vamvakopoulos et al.
The Annals of Pharmacotherapy 2008;42:413-420.
ABSTRACT
| FULL TEXT
Statin Therapy for Stroke Prevention
Nassief and Marsh
Stroke 2008;39:1042-1048.
ABSTRACT
| FULL TEXT
Lipid Management to Reduce Cardiovascular Risk: A New Strategy Is Required
Superko and King
Circulation 2008;117:560-568.
FULL TEXT
Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in Women: Analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA Study)
Mizuno et al.
Circulation 2008;117:494-502.
ABSTRACT
| FULL TEXT
Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis
Jenkins et al.
CMAJ 2008;178:157-164.
ABSTRACT
| FULL TEXT
Adolescent Overweight and Future Adult Coronary Heart Disease
Bibbins-Domingo et al.
NEJM 2007;357:2371-2379.
ABSTRACT
| FULL TEXT
Family practice patients' adherence to statin medications
Natarajan et al.
cfp 2007;53:2144-2145.
ABSTRACT
| FULL TEXT
Impact of Statins on Risk of Stroke: A Meta-Analysis
Henyan et al.
The Annals of Pharmacotherapy 2007;41:1937-1945.
ABSTRACT
| FULL TEXT
Primary Prevention of Coronary Artery Disease
Domanski
NEJM 2007;357:1543-1545.
FULL TEXT
Impact of C-reactive protein on treatment of patients with cardiovascular disease
Gortney and Sanders
Am J Health Syst Pharm 2007;64:2009-2016.
ABSTRACT
| FULL TEXT
Simvastatin Protects against Multiple Low-Dose Streptozotocin-Induced Type 1 Diabetes in CD-1 Mice and Recurrence of Disease in Nonobese Diabetic Mice
Rydgren et al.
J. Pharmacol. Exp. Ther. 2007;323:180-185.
ABSTRACT
| FULL TEXT
Preprocedural Statin Therapy in Percutaneous Coronary Intervention
Cahoon and Crouch
The Annals of Pharmacotherapy 2007;41:1687-1693.
ABSTRACT
| FULL TEXT
Discontinuation of Statin Therapy and Clinical Outcome After Ischemic Stroke
Colivicchi et al.
Stroke 2007;38:2652-2657.
ABSTRACT
| FULL TEXT
HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events
Barter et al.
NEJM 2007;357:1301-1310.
ABSTRACT
| FULL TEXT
Are patients with hyperlipidemia undertreated?: Study of patients admitted to hospital with coronary events
Lipson et al.
cfp 2007;53:1502-1507.
ABSTRACT
| FULL TEXT
High-Density Lipoprotein as a Therapeutic Target: A Systematic Review
Singh et al.
JAMA 2007;298:786-798.
ABSTRACT
| FULL TEXT
Statins and the Risk of Colorectal Cancer: A Meta-Analysis of 18 Studies Involving More Than 1.5 Million Patients
Bonovas et al.
JCO 2007;25:3462-3468.
ABSTRACT
| FULL TEXT
Statin-Induced Breast Cancer Cell Death: Role of Inducible Nitric Oxide and Arginase-Dependent Pathways
Kotamraju et al.
Cancer Res. 2007;67:7386-7394.
ABSTRACT
| FULL TEXT
Effect of the Magnitude of Lipid Lowering on Risk of Elevated Liver Enzymes, Rhabdomyolysis, and Cancer: Insights From Large Randomized Statin Trials
Alsheikh-Ali et al.
J Am Coll Cardiol 2007;50:409-418.
ABSTRACT
| FULL TEXT
The Unique Character of Cardiovascular Disease in Chronic Kidney Disease and Its Implications for Treatment with Lipid-Lowering Drugs
Nogueira and Weir
CJASN 2007;2:766-785.
ABSTRACT
| FULL TEXT
Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group
Arnett et al.
Circulation 2007;115:2878-2901.
ABSTRACT
| FULL TEXT
Type 2 diabetes patients: profiles, treatment and daily practice
Zambon
Diabetes and Vascular Disease Research 2007;4:S12-S16.
The Role of Statins in Primary Prevention of Cardiovascular Disease
Eichler et al.
Arch Intern Med 2007;167:1100-1100.
FULL TEXT
Statins: Targeting Inflammation by Lowering Low-Density Lipoprotein?
Tuzcu and Nicholls
J Am Coll Cardiol 2007;49:2010-2012.
FULL TEXT
Low-Density Lipoprotein-Dependent and -Independent Effects of Cholesterol-Lowering Therapies on C-Reactive Protein: A Meta-Analysis
Kinlay
J Am Coll Cardiol 2007;49:2003-2009.
ABSTRACT
| FULL TEXT
Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? Yes
Grundy
BMJ 2007;334:982-982.
FULL TEXT
Statins Reduce the Risk of Lung Cancer in Humans: A Large Case-Control Study of US Veterans
Khurana et al.
Chest 2007;131:1282-1288.
ABSTRACT
| FULL TEXT
Safety of Aggressive Lipid Management
Davidson and Robinson
J Am Coll Cardiol 2007;49:1753-1762.
ABSTRACT
| FULL TEXT
A review of high-dose statin therapy: targeting cholesterol and inflammation in atherosclerosis
Patel et al.
Eur Heart J 2007;28:664-672.
ABSTRACT
| FULL TEXT
Inhibition of 3-Hydroxy-3-Methylglutaryl Coenzyme A (HMG CoA) Reductase Blunts Factor VIIa/Tissue Factor and Prothrombinase Activities via Effects on Membrane Phosphatidylserine
Dietzen et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:690-696.
ABSTRACT
| FULL TEXT
High-Density Lipoprotein Cholesterol: An Emerging Target for Stroke Treatment
Sanossian et al.
Stroke 2007;38:1104-1109.
ABSTRACT
| FULL TEXT
Does pravastatin promote cancer in elderly patients? A meta-analysis
Bonovas and Sitaras
CMAJ 2007;176:649-654.
ABSTRACT
| FULL TEXT
Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis
Nicholls et al.
JAMA 2007;297:499-508.
ABSTRACT
| FULL TEXT
The Use of Statins in Pediatrics: Knowledge Base, Limitations, and Future Directions
Belay et al.
Pediatrics 2007;119:370-380.
ABSTRACT
| FULL TEXT
The effect of intensive lipid lowering on coronary atheroma and clinical outcome
Houslay et al.
Heart 2007;93:149-151.
ABSTRACT
| FULL TEXT
Is it Time for a Cardiovascular Primary Prevention Trial in the Elderly?
Robinson et al.
Stroke 2007;38:441-450.
ABSTRACT
| FULL TEXT
Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive Protein: The PIOSTAT Study
Hanefeld et al.
J Am Coll Cardiol 2007;49:290-297.
ABSTRACT
| FULL TEXT
Statin Use and Risk of Colorectal Cancer
Coogan et al.
JNCI J Natl Cancer Inst 2007;99:32-40.
ABSTRACT
| FULL TEXT
Rational therapy of mixed dyslipidaemia in a patient with diabetes
Reasner
British Journal of Diabetes & Vascular Disease 2007;7:25-30.
ABSTRACT
Inhibition of CETP as a novel therapeutic strategy for reducing the risk of atherosclerotic disease
Shah
Eur Heart J 2007;28:5-12.
ABSTRACT
| FULL TEXT
Advances In The Prevention And Treatment Of Cardiovascular Disease
Weisfeldt and Zieman
Health Aff (Millwood) 2007;26:25-37.
ABSTRACT
| FULL TEXT
The Nitric Oxide-Donating Pravastatin Derivative, NCX 6550 [(1S-[1{alpha}(betaS*, {delta}S*), 2{alpha}, 6{alpha}, 8beta-(R*), 8a{alpha}]]-1,2,6,7,8,8a-Hexahydro-beta, {delta}, 6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphtalene-heptanoic Acid 4-(Nitrooxy)butyl Ester)], Reduces Splenocyte Adhesion and Reactive Oxygen Species Generation in Normal and Atherosclerotic Mice
Dever et al.
J. Pharmacol. Exp. Ther. 2007;320:419-426.
ABSTRACT
| FULL TEXT
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part I: Pathophysiology and Clinical Trial Evidence (Risk Factors Through Stable Coronary Artery Disease)
Dzau et al.
Circulation 2006;114:2850-2870.
FULL TEXT